Skip to main content
. Author manuscript; available in PMC: 2021 Nov 17.
Published in final edited form as: Immunity. 2020 Oct 5;53(5):1001–1014.e20. doi: 10.1016/j.immuni.2020.09.003

Figure 4. MHCII expression by epithelial cells is required for CD4+CD8αα+ IEL differentiation.

Figure 4.

(A-C) Flow cytometry analysis of the intestinal epithelium (IE) of iVil1WT(MHCII) (H2-Ab1+/+ Vil1creERT2+/− or H2-Ab1f/f Vil1creERT2−/−) and iVil1 Δ(MHCII) (H2-Ab1f/f Vil1creERT2+/+) mice after tamoxifen administration to mice of different ages as indicated. Dot plots of surface CD8α and TL-Tetramer expression among CD4+ T cells (left). Frequencies of CD4+CD8αα+ IELs (CD4+CD8α+TL-Tetramer+) or Foxp3+ regulatory cells (Treg) among CD4+ T cells (middle). Frequencies of pre-IELs (CD4+CD103+) among CD4+SP (CD4+CD8αFoxp3) cells and frequencies of total CD4+ cells among TCRαβ+ cells (right). Data are expressed as mean +/− SEM of individual mice (n=7–15, 3–6 independent experiments per timepoint). Significant p values as indicated [student’s t test (A-C)]. See also Figure S4.